title: Statement 6: patients who are unresponsive to GH therapy should be given a trial of IGF-I.
authors.affiliation: Division of Endocrinology, Metabolism & Diabetes, Department of Pediatrics, Columbus Children's Hospital, Ohio State University, Columbus, Ohio, USA.
authors.forename: Dana S
authors.initials: DS
authors.lastname: Hardin
mesh_terms: D002648:Child; D004351:Drug Resistance; D019317:Evidence-Based Medicine; D019382:Human Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000627:therapeutic use*; D046150:Laron Syndrome / Q000188:drug therapy*
chemical_list: D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I